Fatigue, hair loss, mood changes, and low libido: why the whole pattern matters
A fictional composite vignette shows why overlapping symptoms deserve a structured evaluation—without assuming a single hormonal, thyroid, or nutritional cause.
Short answer
The symptom cluster is real. The explanation is not automatically singular.
Fatigue, hair loss, difficulty concentrating, premenstrual symptoms, and low sexual desire can coexist for different reasons. A structured evaluation begins with timing, menstrual pattern and blood loss, sleep, mood, nutrition, medications, supplements, and physical findings. Tests should answer defined questions. In the fictional follow-up, some symptoms change while others persist; that uneven course organizes reassessment but does not prove that any product, hormone, or supplement caused the change.
Build the timeline
Ask what began first, what fluctuates with the menstrual cycle, and what changed around sleep, stress, nutrition, medication, or reproductive events.
Separate the symptoms
Fatigue, hair loss, premenstrual distress, and sexual concerns may overlap while still requiring different clinical questions.
Target the tests
A laboratory panel is useful only when each result can test a plausible hypothesis or change the next step.
Reassess unevenly
Improvement in one complaint does not close the evaluation of another complaint that persists or worsens.
Bottom lineA list of symptoms can guide questions. It cannot, by itself, diagnose a thyroid disorder, vitamin deficiency, menopause transition, or a testosterone deficiency.
Pattern map
The same complaint can point to more than one line of inquiry
MERHI ONE evidence review
What the evidence supports—and what it does not
Each rating applies to the exact claim below. Evidence for one component should not be stretched into an explanation for the entire cluster.
Persistent fatigue should be evaluated through history and examination before indiscriminate testing.1
Sleep quality, mental health, substance use, medications, nutrition, symptom pattern, and signs of systemic illness shape the differential diagnosis. Broad untargeted testing can generate incidental abnormalities without explaining the complaint.
Symptoms can raise a thyroid question, but TSH and free T4 are needed to classify thyroid function.2
Fatigue, cold sensitivity, constipation, dry skin, and hair changes are nonspecific. Subclinical hypothyroidism is a biochemical pattern—not a symptom-based diagnosis—and unexpected or mild abnormalities often require confirmation and context.
Heavy menstrual bleeding can justify evaluation for anemia and possible iron deficiency.3
Bleeding history and impact matter. NICE recommends a full blood count for women with heavy menstrual bleeding; additional iron assessment depends on the clinical question and local practice rather than a universal supplement-first approach.
Premenstrual disorders are defined by timing and impairment, not by one severe month or retrospective recall alone.4,5
Prospective daily symptom recording over at least two cycles helps distinguish PMS or PMDD from symptoms that remain present throughout the month or represent premenstrual worsening of another condition.
Nonspecific symptoms alone do not establish perimenopause or the menopause transition.6
Age, menstrual-cycle change, reproductive history, medications, and alternative causes all matter. Early or premature ovarian insufficiency follows a distinct diagnostic pathway and should not be inferred from fatigue, mood, skin, or sexual symptoms alone.
Low sexual desire is multifactorial, and no serum testosterone cutoff diagnoses its cause in women.7,8,13
Assessment should include distress, relationship and sexual context, pain or dryness, mood, sleep, medications, reproductive stage, and relevant health conditions. The best-supported testosterone indication is carefully assessed HSDD in postmenopausal women; evidence is insufficient for broad use in premenopausal women or for nonspecific symptoms.
A low vitamin D result may be clinically relevant without explaining the entire symptom cluster.9
The 2024 Endocrine Society guideline discourages routine vitamin D testing in generally healthy adults without an established indication. Associations between low 25(OH)D and nonspecific symptoms do not prove that supplementation will resolve fatigue, mood, hair, or libido concerns.
Lower iron stores are associated with some forms of nonscarring hair loss, but the evidence does not support one universal ferritin target for hair growth.10
A systematic review found iron deficiency more common among women with nonscarring alopecia, with substantial variation among studies. Association does not identify the cause of hair loss or prove benefit from iron when deficiency is absent.
Zinc supplements can cause nausea and gastric distress, especially as total intake rises.11
Product combinations can duplicate zinc. High intake can also impair copper absorption over time. Improvement after stopping a product supports an intolerance hypothesis but does not identify the ingredient with certainty.
Brazil · United States · Europe
The clinical reasoning is shared. Guidance, tests, and approved treatments remain local.
This English edition is written for readers in the United States and Europe. It uses an international scientific core without treating Europe as one health system or transferring one country's rules to another.
United States
Use current U.S. guidance, laboratory methods, FDA status, insurance pathways, and a clinician licensed where care is delivered.
Europe and the United Kingdom
Use current national guidance and local regulatory pathways. The United Kingdom, European Union, and individual European countries do not share one identical health or medicines system.
Brazil
Use Brazilian professional and public-health guidance, ANVISA rules, local laboratory context, and a clinician legally qualified in Brazil.
A structured first pass
Seven questions that organize the next step
What is the timeline?
Record onset, daily pattern, progression, triggers, and whether symptoms began together or years apart.
Is there a menstrual pattern?
Track cycle dates, bleeding burden, premenstrual timing, and symptom-free intervals.
How are sleep and mental health?
Explore sleep duration and quality, snoring or apnea risk, depression, anxiety, stress, trauma, and safety.
What is the nutrition and activity context?
Review food intake, weight trajectory, hydration, bowel pattern, training load, and recovery.
What is being taken?
List prescriptions, hormones, contraceptives, over-the-counter products, compounded products, and every supplement with dose and timing.
Which test answers which question?
Possible testing is individualized; the history and examination determine whether blood count, iron status, thyroid tests, pregnancy testing, or other investigations are appropriate.
Which symptom remains?
Follow each complaint separately. Persistent hair loss, sexual distress, mood symptoms, or fatigue may require a different pathway or referral.
Common reasoning errors
What this vignette should never be used to justify
A fictional educational scenario cannot validate a diagnosis, protocol, compounded formula, or treatment result.
Diagnosing from a checklist
Many conditions share these symptoms, and more than one factor may coexist.
Ordering a universal panel
Testing without a defined question increases false positives and incidental findings.
Calling low libido “low testosterone”
Female sexual function is biopsychosocial; one concentration does not establish the cause.
Attributing every change to treatment
Timing alone cannot separate treatment effects from natural variation, concurrent changes, expectancy, or regression to the mean.
Copying a prescription
A hormone or supplement plan cannot be transferred safely without diagnosis, contraindications, reproductive plans, interactions, and monitoring.
Ignoring adverse effects
Nausea, gastric pain, palpitations, mood deterioration, or new symptoms require reassessment rather than automatic continuation.
Questions
What readers usually want to know
If my tests are normal, does that mean the symptoms are not real?+
No. Reference-range results do not invalidate symptoms. They may narrow some hypotheses while prompting a review of timing, sleep, mental health, medications, nutrition, reproductive factors, or other causes.
Do these symptoms mean hypothyroidism?+
Not necessarily. They can justify thyroid evaluation, but diagnosis depends on the clinical context and properly interpreted laboratory results.
Does low libido mean low testosterone?+
No. Desire is multifactorial, and no isolated testosterone value diagnoses the cause of low desire in women.
Could vitamin D explain everything?+
A low result may deserve attention, but it does not establish that vitamin D is the cause of fatigue, hair loss, mood changes, or low libido.
Which tests should I order?+
There is no universal panel. A locally licensed clinician should select tests after the history and examination define the most plausible questions.
Does improvement after starting treatment prove it worked?+
No. A temporal change matters for follow-up, but an individual observation cannot establish which intervention caused it or whether the same approach would help another person.
References
Guidelines, consensus statements, and systematic evidence
The scientific core combines fatigue evaluation, thyroid and menstrual guidance, sexual-health consensus, vitamin D recommendations, hair-loss evidence, and supplement safety. Local implementation can differ.
- 01Open source ↗
American Family Physician · 2023
Fatigue in Adults: Evaluation and Management
- 02Open source ↗
NICE · current guideline
Thyroid disease: assessment and management (NG145)
- 03Open source ↗
NICE · current guideline
Heavy menstrual bleeding: assessment and management (NG88)
- 04Open source ↗
American College of Obstetricians and Gynecologists · 2023
Management of Premenstrual Disorders: Clinical Practice Guideline No. 7
- 05Open source ↗
Royal College of Obstetricians and Gynaecologists · current guidance
Managing premenstrual syndrome (PMS)
- 06Open source ↗
European Society of Endocrinology · 2025
Clinical Practice Guideline for the evaluation and management of menopause and the perimenopause
- 07Open source ↗
International consensus · 2019
Global Consensus Position Statement on the Use of Testosterone Therapy for Women
- 08Open source ↗
ISSWSH · 2021
Clinical Practice Guideline for Systemic Testosterone in Women with HSDD
- 09Open source ↗
Endocrine Society · 2024
Vitamin D for the Prevention of Disease: Clinical Practice Guideline
- 10Open source ↗
Skin Appendage Disorders · 2022
Iron Deficiency and Nonscarring Alopecia in Women: Systematic Review and Meta-Analysis
- 11Open source ↗
NIH Office of Dietary Supplements · 2026
Zinc: Health Professional Fact Sheet
- 12Open source ↗
Ministério da Saúde do Brasil · current resource
Primary Care Protocols: Women's Health
- 13Open source ↗
Agência Nacional de Vigilância Sanitária (Anvisa) · 2026
Testosterone replacement is not universally required for women
Editorial record